收稿日期: 2024-12-10
录用日期: 2025-02-26
网络出版日期: 2025-06-28
基金资助
国家自然科学基金(82170976);上海市“科技创新行动计划”启明星项目(扬帆专项)(22YF1422300)
Preliminary study on early warning value and mechanism of interleukin-1β in extremely severe oral and maxillofacial space infections
Received date: 2024-12-10
Accepted date: 2025-02-26
Online published: 2025-06-28
Supported by
National Natural Science Foundation of China(82170976);Shanghai Young Science and Technology Talents Sailing Program(22YF1422300)
目的·探究白介素-1β(interleukin-1β,IL-1β)在预测口腔颌面间隙感染(oral and maxillofacial space infection,OMSI)严重程度的作用,并探索影响IL-1β释放的关键机制、关键细胞亚群及OMSI患者免疫细胞间通信网络。方法·选取2023年1月至2023年11月就诊于上海交通大学医学院附属第九人民医院口腔外科的OMSI患者共62例,包括中度感染20例、重度感染21例和极重度感染21例,采用Logistic回归分析影响极重度感染的危险因素,绘制受试者操作特征曲线(receiver operating characteristic curve,ROC)评估上述指标预测极重度感染的能力。分别选取2例中度、重度和极重度患者的外周血单个核细胞(peripheral blood mononuclear cell,PBMC),结合2名健康对照(GSE224198)进行单细胞RNA测序(single-cell RNA sequencing,scRNA-seq)分析,明确促炎关键细胞亚群及关键基因随着感染程度加重的变化趋势,通过CellChat分析细胞间通信。通过实时荧光定量聚合酶链反应(quantitative real-time polymerase chain reaction,qPCR)及Western blotting验证PBMC中炎性小体激活水平。结果·与中度和重度感染患者相比,极重度感染患者降钙素原(procalcitonin,PCT)(P<0.05)和IL-1β(P<0.05)水平显著升高。Logistic回归显示IL-1β是极重度感染的独立危险因素(OR=1.814,95%CI 1.256~2.621,P=0.002)。联合IL-1β和PCT预测极重度感染的ROC曲线下面积(area under the curve,AUC)为0.943。scRNA-seq显示,感染加重过程中单核细胞NOD样受体热蛋白结构域相关蛋白3(NOD-like receptor family pyrin domain-containing 3,NLRP3)基因、IL1B基因表达持续上调,中间型单核细胞是表达IL1B基因的主要细胞亚群。IL-1Β-IL-1R信号通信、趋化因子配体(C-C motif chemokine ligand,CCL)和细胞间黏附分子(intercellular adhesion molecule,ICAM)信号通信在单核细胞中显著增强;T细胞与单核细胞间巨噬细胞迁移抑制因子(macrophage migration inhibitory factor,MIF)信号通信亦显著增强。随着感染的加重,外周血NLRP3和IL1B的mRNA水平逐渐升高,NLRP3、caspase-1 p20、凋亡相关斑点样蛋白(apoptosis-associated speck-like protein containing a CARD,ASC)、IL-1β蛋白表达水平持续升高。结论·联合入院IL-1β和PCT水平可有效预测OMSI极重度感染。感染患者PBMC中NLRP3炎性小体激活。IL-1β的升高与中间型单核细胞密切相关,同时单核细胞介导的IL-1Β-IL-1R、CCL、ICAM信号通信及T细胞介导的MIF信号通信共同促进炎症反应。
朱晗懿 , 石欢 , 俞创奇 , 郑凌艳 . 白介素-1β在极重症口腔颌面部感染中的预警价值及机制初探[J]. 上海交通大学学报(医学版), 2025 , 45(6) : 661 -672 . DOI: 10.3969/j.issn.1674-8115.2025.06.001
Objective ·To investigate the role of interleukin-1β (IL-1β) in predicting the severity of oral and maxillofacial space infection (OMSI), and to explore the key mechanisms regulating IL-1β release, the critical immune cell subpopulations involved, and the intercellular communication networks among immune cells in OMSI patients. Methods ·A total of 62 OMSI patients admitted to the Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, from January to November 2023 were enrolled, including 20 patients with moderate infection, 21 with severe infection, and 21 with extremely severe infection. Logistic regression analysis was performed to identify risk factors for extremely severe infection, and receiver operating characteristic (ROC) curves were constructed to evaluate the ability of the above indicators to predict extremely severe infection. Peripheral blood mononuclear cells (PBMCs) from 2 patients in each group (moderate, severe and extremely severe) and 2 healthy controls (GSE224198) were analyzed using single-cell RNA sequencing (scRNA-seq) to identify key pro-inflammatory cell subtypes and genes, and to examine their changing trends with increasing infection severity. Cell-cell communication was assessed using CellChat. Quantitative real-time polymerase chain reaction (qPCR) and Western blotting were used to validate inflammasome activation levels in PBMCs. Results ·Compared with patients with moderate and severe infections, levels of procalcitonin (PCT) (P<0.05) and IL-1β (P<0.05) were significantly elevated in patients with extremely severe infection. Logistic regression identified IL-1β as an independent risk factor for extremely severe infection (OR=1.814, 95% CI 1.256‒2.621, P=0.002). The area under the ROC curve (AUC) for the combined prediction of extremely severe infection using IL-1β and PCT was 0.943. scRNA-seq revealed continuous upregulation of NLRP3 (NOD-like receptor family pyrin domain-containing 3) and IL1B gene expression in monocytes as infection severity increased, with intermediate monocytes being the main IL1B-expressing cell subtype. IL-1Β-IL-1R signaling, C-C motif chemokine ligand (CCL) and intercellular adhesion molecule (ICAM) signaling were significantly enhanced in monocytes. Macrophage migration inhibitory factor (MIF) signaling between T cells and monocytes also increased notably. With infection progression, the mRNA levels of NLRP3 and IL1B in peripheral blood rose steadily, and the protein levels of NLRP3, caspase-1 p20, apoptosis-associated speck-like protein containing a CARD (ASC) and IL-1β were persistently elevated. Conclusion ·The combined levels of IL-1β and PCT at admission can effectively predict extremely severe OMSI. NLRP3 inflammasome activation is observed in PBMCs of OMSI patients. The elevation of IL-1β is closely associated with intermediate monocytes. Monocyte-mediated IL-1Β-IL-1R, CCL and ICAM signaling pathways, along with T cell-mediated MIF signaling pathways, collectively promote the inflammatory response.
[1] | MEISGEIER A, PIENKOHS S, DüRRSCHNABEL F, et al. Rising incidence of severe maxillofacial space infections in Germany[J]. Clin Oral Investig, 2024, 28(5): 264. |
[2] | ROBERTSON D D, SMITH A J. Significant increase in hospital admissions for the management of severe dental infection in England 2000-2020[J]. J Infect, 2021, 83(4): 496-522. |
[3] | QIAN Y Z, GE Q, ZUO W, et al. Maxillofacial space infection experience and risk factors: a retrospective study of 222 cases[J]. Ir J Med Sci, 2021, 190(3): 1045-1053. |
[4] | CARRASCOSA M F, CAYóN HOYO S, ECHEVERRíA SAN-SEBASTIáN R, et al. Descending necrotizing mediastinitis from ludwig's angina: a life-threatening condition[J]. Eur J Clin Microbiol Infect Dis, 2022, 41(1): 181-183. |
[5] | BULEK K, ZHAO J J, LIAO Y, et al. Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis[J]. J Clin Invest, 2020, 130(8): 4218-4234. |
[6] | LI Y, JIANG Q Z. Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling[J]. Front Immunol, 2023, 14: 1128358. |
[7] | YANG X Y, CHENG X Y, TANG Y T, et al. Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure[J]. Immunity, 2019, 51(6): 983-996.e6. |
[8] | BUSCH K, KNY M, HUANG N, et al. Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy[J]. J Cachexia Sarcopenia Muscle, 2021, 12(6): 1653-1668. |
[9] | VIGNERON C, PY B F, MONNERET G, et al. The double sides of NLRP3 inflammasome activation in sepsis[J]. Clin Sci (Lond), 2023, 137(5): 333-351. |
[10] | WANG B L, ZHOU Q, QIAN W T, et al. The predictive value of laboratory tests in oro-maxillofacial infection of different severity[J]. Oral Dis, 2024, 30(3): 1695-1701. |
[11] | HUANG L J, JIANG B, CAI X Y, et al. Multi-space infections in the head and neck: do underlying systemic diseases have a predictive role in life-threatening complications?[J]. J Oral Maxillofac Surg, 2015, 73(7): 1320.e1-1320.10. |
[12] | LI X J, LIU H, GONG Z C, et al. The predictive value of interleukin-6 and neutrophil-lymphocyte ratio in patients with severe and extremely severe oral and maxillofacial space infections[J]. Biomed Res Int, 2021, 2021: 2615059. |
[13] | KANG S J, KISHIMOTO T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms[J]. Exp Mol Med, 2021, 53(7): 1116-1123. |
[14] | MILLS K H G. IL-17 and IL-17-producing cells in protection versus pathology[J]. Nat Rev Immunol, 2023, 23(1): 38-54. |
[15] | PAIK S, KIM J K, SILWAL P, et al. An update on the regulatory mechanisms of NLRP3 inflammasome activation[J]. Cell Mol Immunol, 2021, 18(5): 1141-1160. |
[16] | BARNETT K C, LI S R, LIANG K X, et al. A 360° view of the inflammasome: mechanisms of activation, cell death, and diseases[J]. Cell, 2023, 186(11): 2288-2312. |
[17] | HATSCHER L, AMON L, HEGER L, et al. Inflammasomes in dendritic cells: friend or foe?[J]. Immunol Lett, 2021, 234: 16-32. |
[18] | CUI J, OEHRL S, AHMAD F, et al. Detection of in vivo inflammasome activation for predicting sepsis mortality[J]. Front Immunol, 2021, 11: 613745. |
[19] | CROS J, CAGNARD N, WOOLLARD K, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors[J]. Immunity, 2010, 33(3): 375-386. |
[20] | PATEL V K, WILLIAMS H, LI S C H, et al. Monocyte inflammatory profile is specific for individuals and associated with altered blood lipid levels[J]. Atherosclerosis, 2017, 263: 15-23. |
[21] | WONG K L, YEAP W H, TAI J J Y, et al. The three human monocyte subsets: implications for health and disease[J]. Immunol Res, 2012, 53(1/2/3): 41-57. |
[22] | WILLIAMS H, MACK C, BARAZ R, et al. Monocyte differentiation and heterogeneity: inter-subset and interindividual differences[J]. Int J Mol Sci, 2023, 24(10): 8757. |
[23] | O?A?SKA A, SZYMCZAK D, RYBKA J. Pattern of human monocyte subpopulations in health and disease[J]. Scand J Immunol, 2020, 92(1): e12883. |
[24] | KIM H K, GARCIA A B, SIU E, et al. Macrophage migration inhibitory factor regulates innate γδ T-cell responses via IL-17 expression[J]. FASEB J, 2019, 33(6): 6919-6932. |
[25] | SUMAIYA K, LANGFORD D, NATARAJASEENIVASAN K, et al. Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies[J]. Pharmacol Ther, 2022, 233: 108024. |
[26] | BOZZA F A, GOMES R N, JAPIASSú A M, et al. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis[J]. Shock, 2004, 22(4): 309-313. |
[27] | STIJLEMANS B, SCHOOVAERTS M, DE BAETSELIER P, et al. The role of MIF and IL-10 as molecular Yin-Yang in the modulation of the host immune microenvironment during infections: African trypanosome infections as a paradigm[J]. Front Immunol, 2022, 13: 865395. |
[28] | 蒋文, 石丁华, 何艳娟, 等. 降钙素原对脂多糖诱导的人脐静脉内皮细胞NLRP3和caspase-1表达的影响[J]. 中国当代儿科杂志, 2023, 25(5): 521-526. |
JIANG W, SHI D H, HE Y J, et al. Effect of procalcitonin on lipopolysaccharide-induced expression of nucleotide-binding oligomerization domain-like receptor protein 3 and caspase-1 in human umbilical vein endothelial cells[J]. Chin J Contemp Pediatr, 2023, 25(5): 521-526. | |
[29] | WEI Z Y, ZHAN X Y, DING K X, et al. Dihydrotanshinone Ⅰ specifically inhibits NLRP3 inflammasome activation and protects against septic shock in vivo[J]. Front Pharmacol, 2021, 12: 750815. |
[30] | TANUSEPUTERO S A, LIN M T, YEH S L, et al. Intravenous arginine administration downregulates NLRP3 inflammasome activity and attenuates acute kidney injury in mice with polymicrobial sepsis[J]. Mediators Inflamm, 2020, 2020: 3201635. |
[31] | WEI S S, XIAO Z J, HUANG J, et al. Disulfiram inhibits oxidative stress and NLRP3 inflammasome activation to prevent LPS-induced cardiac injury[J]. Int Immunopharmacol, 2022, 105: 108545. |
[32] | SHI X Y, LI T, LIU Y T, et al. HSF1 protects sepsis-induced acute lung injury by inhibiting NLRP3 inflammasome activation[J]. Front Immunol, 2022, 13: 781003. |
/
〈 |
|
〉 |